Cipatinib

cipatinib · Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cipatinib, covering 2012-12-21 to 2012-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer [Phase 1]